Product Information
LATUDA 120 MG TABLET is a brand product labeled by Sumitomo Pharma America, Inc., priced at $69.2795 per EA under NDC 63402031230. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Oct 28, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the lurasidone hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
120 mg/1
Manufacturer
Sumitomo Pharma America, Inc.NDC
63402031230
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LURASIDONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA200603FDA Approved
10/28/2010
TE Code
AB
On Market Since
4/26/2012
Pharmacological Classes
Price Statistics
The NADAC for LATUDA 120 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 137.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $69.2795 per EA |
|---|---|
| All-time high | $69.6208 (Jun 10, 2026) |
| All-time low | $29.2222 (Nov 28, 2013) |
| 52-week high | $69.6208 |
| 52-week low | $67.4674 |
| Median price | $61.2109 |
| Average price | $57.1683 |
| Largest weekly change | +9.9% (Jan 14, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LATUDA 120 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LATUDA 120 MG TABLET, manufactured by Sumitomo Pharma America, Inc., is $69.2795 per EA (NDC 63402031230), effective Aug 19, 2026.
How has the price of LATUDA 120 MG TABLET changed over time?
Over the history we have for it, the NADAC for LATUDA 120 MG TABLET has risen 137.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LATUDA 120 MG TABLET?
Since Nov 28, 2013, the NADAC for LATUDA 120 MG TABLET has ranged from a low of $29.2222 (Nov 28, 2013) to a high of $69.6208 (Jun 10, 2026), with a median of $61.2109 per EA.
Are there cheaper alternatives to LATUDA 120 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LURASIDONE HCL 120 MG TABLET, is $0.4824 per EA — about 99% below LATUDA 120 MG TABLET.
Who manufactures LATUDA 120 MG TABLET?
LATUDA 120 MG TABLET (NDC 63402031230) is labeled by Sumitomo Pharma America, Inc., and CMS classifies it as a brand product.